CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma
Egile Nagusiak: | Guang Wang, Juan Fu, Mulin Liu, Qin Zheng |
---|---|
Formatua: | Artikulua |
Hizkuntza: | English |
Argitaratua: |
Public Library of Science (PLoS)
2024-01-01
|
Saila: | PLoS ONE |
Sarrera elektronikoa: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10793908/?tool=EBI |
Antzeko izenburuak
-
CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma.
nork: Guang Wang, et al.
Argitaratua: (2024-01-01) -
The Role of CXC Chemokines in Cardiovascular Diseases
nork: Xiyi Lu, et al.
Argitaratua: (2022-05-01) -
FEATURES OF LOCAL mRNA SYNTHESIS FOR SOME CC- AND CXC-CHEMOKINES AND THEIR RECEPTORS IN ENDOMETRIAL HYPERPLASIA
nork: N. V. Kipich, et al.
Argitaratua: (2014-07-01) -
Depleted-MLH1 Expression Predicts Prognosis and Immunotherapeutic Efficacy in Uterine Corpus Endometrial Cancer: An In Silico Approach
nork: Tesfaye Wolde, et al.
Argitaratua: (2024-02-01) -
Regulation of Expression of CXC Chemokines in Cultured Hepatocytes
nork: GhH Hassanshahiraviz, et al.
Argitaratua: (2005-03-01)